254: How to Source, Manufacture, and Scale the Earliest Stem Cells for Allogeneic Cell Therapy Without Ethical Barriers with Yuta Lee - Part 2

254: How to Source, Manufacture, and Scale the Earliest Stem Cells for Allogeneic Cell Therapy Without Ethical Barriers with Yuta Lee - Part 2

From Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders by David Brühlmann - CMC Development Leader, Bioprocess Expert, Business Strategist

May 21, 2026 · 22 min · Episode 254

About this episode

The episode discusses the potential of super-early stem cells in slowing or reversing biological aging.

Can aging be fundamentally slowed or even reversed—not by science fiction, but by harnessing the unassuming power of super-early stem cells? In Part 1, Yuta Lee, Founder and CEO of Accelerated Bio, walked through the biology, ethical sourcing, and manufacturing profile of human trophoblast stem cells. In Part 2, the conversation shifts to the larger ambition: using those cells not just to treat disease, but to slow, stop, or reverse biological aging itself. The evidence starts with a striking...

People in this episode

Host: David Brühlmann

Guest: Yuta Lee

Topics covered

  • stem cells
  • allogeneic cell therapy
  • biological aging
  • ethical sourcing
  • manufacturing

Keywords

  • stem cells
  • allogeneic therapy
  • biological aging
  • ethical sourcing
  • manufacturing

Mentioned in this episode

Organizations: Accelerated Bio

More episodes of Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders

Explore listener stats, chart rankings, contacts and more on the Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders podcast page.